
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.62%
+37.50%
-1.03%
+5.41%
-2.41%
Most Trending
+1.62%
+37.50%
-1.03%
+5.41%
-2.41%
25 Nov 2025$SYM Symbotic stole the show with a jaw-dropping 39.36% surge to $77.29 on absolutely massive volume of 9.79 million shares, nearly 4.5 times its average. The warehouse automation and robotics company crushed its Q4 2025 earnings and dropped some serious growth guidance, targeting 25 to 29% revenue growth for Q1 2026. But here's the kicker: they announced their first customer in the healthcare vertical, opening up an entirely new market for their AI-powered automation solutions. Multiple analysts are calling this a game-changer, with Needham reiterating their Buy rating and raising price targets. The MACD crossing above the signal line added technical fuel to the fundamental fire, and traders piled in hard.
$ANF Abercrombie & Fitch wasn't far behind, rocketing 37.5% to $90.24 on volume of 11.62 million shares, nearly seven times normal. The apparel retailer absolutely crushed Q3 expectations with adjusted EPS of $2.36 versus the $2.16 consensus, and here's the interesting twist: while the Abercrombie namesake brand is cooling off, Hollister is picking up serious momentum with teens. Management raised the bottom end of their full-year profit forecast, signaling confidence that the Hollister surge isn't just a one-quarter fluke. The stock led the entire apparel stores sector higher, though the RSI is now flashing overbought at these levels. Jim Cramer called it a crapshoot, but today's buyers clearly disagree.
$BNED Barnes & Noble Education exploded 36.32% to $9.12 on monster volume of 5.43 million shares compared to its tiny 210K average. This move was all about relief as the company released promising preliminary financial results and, crucially, announced the conclusion of an internal accounting investigation. When a stock has been under that kind of cloud, resolution can trigger violent short covering and sidelined buyers jumping back in. The volume spike tells you everything: this wasn't just a few traders, this was real money rotating back into a name that had been left for dead.
$YGMZ OMingzhu Logistics got absolutely destroyed, plummeting 82.67% to just $0.19 after announcing an $8 million registered direct offering. Volume exploded to 28.51 million shares, over 15 times normal, as shareholders rushed for the exits. Dilution announcements are always painful, but an 82% drop signals that either the pricing was egregious or investors have completely lost faith in management's capital allocation. When a stock loses four-fifths of its value in a single session, it's not just about the offering, it's about trust evaporating.
$TPST Tempest Therapeutics wasn't spared either, dropping 23.34% to $3.20 after announcing an $8.35 million registered direct offering with a concurrent private placement. Biotech dilution is always tough to stomach, especially for smaller companies that burn cash. The modest volume of 639K shares suggests this was mostly existing shareholders heading for the door rather than massive selling pressure, but the damage was done. Without a catalyst or data readout to offset the dilution pain, these moves tend to linger.
Yesterday at 08:36
Yesterday at 08:25
Yesterday at 01:31
Yesterday at 01:24
Yesterday at 01:17
Yesterday at 12:25
Yesterday at 12:02
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Yesterday at 08:36
Yesterday at 08:25
Yesterday at 01:31
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.